Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

ClinicalTrials.gov ID: NCT00702702

Public ClinicalTrials.gov record NCT00702702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Placebo Controlled, Safety and Efficacy Study of the Selective Progesterone Receptor Modulator Proellex® (CDB-4124) in Anemic, Pre-Menopausal Women With Symptomatic Uterine Fibroids Requiring Hysterectomy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Eligible female subjects will be randomly assigned to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately six months, which is comprised of a 4 - 6 week screening period, a three-month drug treatment period, and a one-month follow-up period.

Study identification

NCT ID
NCT00702702
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Repros Therapeutics Inc.
Industry
Enrollment
56 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2008 (Type not available)
Primary completion
Aug 2009 (Actual)
Completion
Aug 2009 (Actual)
Last update posted
Aug 21, 2014

2008 – 2009

United States locations

U.S. sites
30
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
Alabama Clinical Therapeutics Birmingham Alabama 35235 —
Women's Health Research Phoenix Arizona 85015 —
Advanced Clinical Research Institute Anaheim California 92801 —
Impact Clinical Trials Los Angeles California 90057 —
National Institute of Clinical Research Los Angeles California 90057 —
Downtown Women's Health Care Denver Colorado 80218 —
Visions Clinical Research Boynton Beach Florida 33472 —
OB-GYN Associates of Mid-Florida, P.A. Leesburg Florida 34748 —
Segal Institute for Clinical Research Miami Florida 33161 —
Insignia Clinical Research (Tampa Bay Women's Center) Tampa Florida 33607 —
Comprehensive Clinical Trials, LLC West Palm Beach Florida 33409 —
Phoenix Women's Center (eCast) College Park Georgia 30349 —
Clinical Trials Select (ecast) Decatur Georgia 30030 —
Dekalb Gynecology Associates/Legacy Obstetrics & Gynecology (eCast) Decatur Georgia 30035 —
Medical Network for Education and Research Decatur Georgia 30333 —
Smith & Hackney Morrow Georgia 30260 —
Bluegrass Clinical Research, Inc. Louisville Kentucky 40291 —
Clinical Trials Select (ecast) Silver Spring Maryland 20903 —
Phoenix OB-GYN Associates, LLC Moorestown New Jersey 08057 —
Central Brooklyn Medical Group (eCast) Brooklyn New York 11205 —
Rapid Medical Research, Inc.(Elite) Cleveland Ohio 44122 —
HWC Women's Research Center Englewood Ohio 45322 —
SC Clinical Research Center Columbia South Carolina 29201 —
Chattanooga Medical Research, LLC Chattanooga Tennessee 37404 —
Advanced Research Associates Corpus Christi Texas 78414 —
Advances in Health Inc. Houston Texas 77030 —
The Women's Hospital of Texas, Clinical Research Center Houston Texas 77054 —
Centex Research Houston Texas 77079 —
Institute for Women's Health San Antonio Texas 78229 —
Seven Oaks Women's Center San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00702702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00702702 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →